A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
Lists
Only you see this
Abstract
In patients with HBeAg-positive chronic hepatitis B, staggered combination treatment with pegylated interferon-alpha2b and lamivudine may lead to a higher rate of virologic response than lamivudine monotherapy.
BibTeX
@article{chan2005randomized,
author = {Henry Lik‐Yuen Chan and Nancy Leung and Alex Hui and Vincent Wai‐Sun Wong and Choong-Tsek Liew and Angel Mei–Ling Chim and Francis K.L. Chan and Lawrence Cheung–Tsui Hung and Yuk-Tong Lee and John S. Tam and Christopher Wai-Kei Lam and Joseph J.�Y. Sung},
title = {{A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone}},
journal = {Annals},
year = {2005},
doi = {10.7326/0003-4819-142-4-200502150-00006},
}Loading related content...